Global Robotic Angiography System Market Size study, by Technology (X-ray Angiography Systems, CT Angiography Systems, MR Angiography Systems), by Application (Coronary Angiography, Endovascular Angiography, Neuro-Angiography, Onco-Angiography), by Indication (Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Others), by End-User (Hospitals, Specialty Clinics, Diagnostic and Imaging Centers, Academic and Research Institutes) and Regional Forecasts 2022-2028

Global Robotic Angiography System Market is valued at approximately XX in 2021 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2022-2028.Angiography is a minimally invasive medical imaging method used to examine the interiors of various organs and blood arteries in the human body. Healthcare infrastructures are increasingly adopting unique robotic imaging systems for angiography as imaging technology advances and automation becomes more integrated. This is expected to increase global demand for robotic angiography equipment.Obesity, poor eating habits, and increased alcohol use are all contributing to a considerable increase in the global burden of heart and renal disease. 

According to the National Institute of Diabetes and Digestive and Kidney Diseases, about 37 million people, or more than one out of every seven adults in the United States, have chronic kidney disease.Robotic angiography technologies are increasingly being utilised to see the blood arteries in the heart and kidneys in order to accurately identify and diagnose issues while reducing the possibility of human mistakes. 

As a result, the increased burden of such diseases is expected to boost sales in the global market.Although there are various advantages to using robotic angiography systems, some problems such as increased risk of radiation exposure, harm due to catheterized arteries, and unsuitability for critically sick patients, among others, are impeding worldwide market sales.Furthermore, the high cost of angiography operations, the high initial cost of robotic angiography equipment, and restricted reimbursement for angiographic surgeries are inhibiting market expansion. Whereas, emerging market is expected to create growth opportunity in the market over the forecast period.

The key regions considered for the global Robotic Angiography System marketstudy includeAsia Pacific, North America, Europe, Latin America, and Rest of the World.North America is expected to be the most profitable market for robotic angiography systems. The need for robotic angiography systems is increasing as the burden of disorders connected to blood vessels, brain, heart, kidney, and others continue to rise, along with the increased usage of high precision imaging technologies. Whereas, Europe is predicted to grow at a stable CAGR in the global robotic angiography systems marketdue to the rising prevalence of such illnesses is expected to boost market growth in Europe.

Major market players included in this report are:
GE Healthcare
KUKA A
Siemens Healthcare Private Limited
Corindus, Inc.
Philips Healthcare
Shimadzu Medical Systems
Boston Scientific
Abbott
Canon
Medtronic

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. 

The detailed segments and sub-segment of the market are explained below: 

By Technology:
X-ray Angiography Systems
CT Angiography Systems
MR Angiography Systems
By Application:
Coronary Angiography
Endovascular Angiography
Neuro-Angiography
Onco-Angiography

By Indication:
Coronary Artery Disease
Valvular Heart Disease
Congenital Heart Disease
Congestive Heart Failure
Others

By End User:
Hospitals
Specialty Clinics
Diagnostic and Imaging Centers
Academic and Research Institutes

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia 
South Korea
RoAPAC

Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors